Compare IDEXX Laboratories, Inc. (IDXX) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Vipshop Holdings Ltd - ADR — how do they compare? IDEXX Laboratories, Inc. trades at $560 (market cap $44.48B), while Vipshop Holdings Ltd - ADR trades at $14.63 (market cap $7.01B). The key difference: IDEXX Laboratories, Inc. is far larger — about 6.3× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays a 4.25% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | VIPS | |
|---|---|---|
Market Cap | $44.48B | $7.01B |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $20.68 |
52-Week Low | $520.87 | $12.92 |
Enterprise Value | $45.38B | $3.60B |
Dividend Yield | — | 4.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
Vipshop (VIPS) trades at $14.56, up 0.41% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 7.07% net income margin and attractive valuation ratios including a P/E of 6.61. Recent Q1 2026 earnings met expectations, and the company is pursuing growth through an outlet store REIT spin-off strategy. Revenue has stabilized around $106 billion after a slight decline from 2023 peaks.
Outlook remains positive given low valuations and analyst consensus, but risks include competitive pressures in Chinese e-commerce and macroeconomic headwinds. The stock offers value opportunity if execution on outlet strategy drives growth, though investors should monitor revenue trends and industry challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →
